NEXTGEN RESONANSE LABS AS
Operating
Drift av et laboratorium for forskning på ulike bioteknologier med mål
om å eliminere patogene mikroorganismer. Selskapet kan også delta i
andre virksomheter med lignende formål, samt kjøpe og selge aksjer
eller på annen måte engasjere seg i relevante foretak.
Forskning og utviklingsarbeid innen bioteknologi.
Organization
- CEO
- AM
- Chairman of the board
- AM
- Years since formation
- 15 years
- since Jan 9, 2010
- Type
- Limited company
- VAT registered
- No
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 2,000,000
- 1 share class
- Total number of shareholders
- 1
- person
Financials
- Annual total result 2024
- -59,594
- NOK
- Total equity 2024
- -883
- NOK
Last update: Sep 9, 2025
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
AM | Managing Director/CEO | - |
Board
| Name | Role | Shares |
|---|---|---|
AM | Chairman | - |
Others
| Name | Role | Shares |
|---|---|---|
| Accountant | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
MS | - | 100 % directly |
Last update: Nov 14, 2024
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
MS | Ordinary shares | 2,000,000 | 100 % |
Shares owned by the NEXTGEN RESONANSE LABS AS
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
F Closed | NO0010931900 | 120,750 | < 0.01 % |
Last update: Jun 2, 2025
Financials
in NOK
Summary
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total operating income | 0 | -110,650 | 793,850 | 73,081 |
Annual Total Result | -59,594 | -141,759 | 155,607 | 10,110 |
Total assets | -48 | 93,413 | 292,637 | 26,728 |
Total liabilities | 835 | 34,702 | 92,166 | 45,473 |
Total equity | -883 | 58,711 | 200,471 | -18,745 |
P&L
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total operating income | 0 | -110,650 | 793,850 | 73,081 |
Total operating costs | 59,593 | 52,133 | 192,486 | 62,822 |
Operating result | -59,593 | -162,783 | 601,364 | 10,259 |
Financial income/costs | -1 | 21,024 | -338,232 | -149 |
Profit before tax | -59,594 | -141,759 | 263,132 | 10,110 |
Total tax & extraordinary income/cost | 0 | 0 | 107,525 | 0 |
Annual Total Result | -59,594 | -141,759 | 155,607 | 10,110 |
Balance overview
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total fixed assets | 0 | 18,956 | 146,061 | 24,401 |
Total current assets | -48 | 74,457 | 146,576 | 2,327 |
Total assets | -48 | 93,413 | 292,637 | 26,728 |
Short term debt | 835 | 34,702 | 92,166 | 45,473 |
Long term debt | 0 | 0 | 0 | 0 |
Total liabilities | 835 | 34,702 | 92,166 | 45,473 |
Contributed capital | 200,000 | 200,000 | 200,000 | 200,000 |
Retained earnings | -200,883 | -141,289 | 471 | -218,745 |
Total equity | -883 | 58,711 | 200,471 | -18,745 |
Total equity and liabilities | -48 | 93,413 | 292,637 | 26,728 |
Classification
21st company classification
BETA
Small company
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises